TLR8-AS1: Potential Drug Target and Biomarker (G349408)

Target Name: TLR8-AS1

NCBI ID: G349408

TLR8-AS1

Other Name(s): GS1-324M7.6 | TLR8 antisense RNA 1

TLR8-AS1: Potential Drug Target and Biomarker

TLR8-AS1 (also known as GS1-324M7.6) is a protein that is expressed in various tissues and cells throughout the body. It is a member of the TLR (Toll-like receptor) family, which is a group of proteins that play a crucial role in the immune system. TLR8-AS1 is specifically involved in the recognition of bacterial peptidoglycans, which are a type of sugar molecule that is present in many bacteria.

TLR8-AS1 is expressed in many different tissues and cells throughout the body, including the epithelial tissue, the skin, the nervous system, and the immune system. It is also highly expressed in the placenta, which is the tissue that provides nutrients and oxygen to the developing fetus. This suggests that TLR8-AS1 may be involved in the immune response and in the regulation of fetal development.

One of the interesting aspects of TLR8-AS1 is its potential as a drug target. Because TLR8-AS1 is involved in the immune response, researchers are interested in using it to develop new treatments for various diseases. For example, TLR8-AS1 has been shown to be involved in the development of cancer, and it is possible that targeting it may be a way to inhibit the growth of cancer cells.

In addition to its potential as a cancer drug, TLR8-AS1 is also a potential biomarker for certain diseases. Because it is expressed in many different tissues and cells, it may be a useful indicator of the level of inflammation or infection in those tissues. This could make it an useful diagnostic tool for diseases that are characterized by inflammation or infection.

Another potential application of TLR8-AS1 is its use as a diagnostic biomarker for certain autoimmune diseases. Because TLR8-AS1 is expressed in many different tissues and cells, it may be an indicator of the level of autoimmune inflammation in those tissues. This could make it an useful diagnostic tool for diseases that are characterized by autoimmune inflammation, such as rheumatoid arthritis or multiple sclerosis.

In conclusion, TLR8-AS1 is a protein that is expressed in various tissues and cells throughout the body. It is a member of the TLR family and is involved in the immune response and the regulation of fetal development. Because of its potential as a drug target and as a biomarker for certain diseases, TLR8-AS1 is an attractive target for researchers to investigate further.

Protein Name: TLR8 Antisense RNA 1

The "TLR8-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TLR8-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets